Analyst
Jeffries
Equibles does not estimate personal net worth.
Michael Sarkone is recorded as Analyst at Jeffries. Michael Sarkone has spoken on 3 earnings calls across 3 companies, most recently for Lemaitre Vascular Inc on August 4, 2026. Those appearances were for Lemaitre Vascular Inc (LMAT), Axogen, Inc. (AXGN) and Cytosorbents Corp (CTSO). The companies whose calls Michael Sarkone spoke on are classified in the Healthcare sector.
“And then just, you know, on the RFA supply constraints, I guess, how are you thinking about next steps here and maybe any timelines for when you could see some relief on those constraints?”
“So just two for me on guidance to start. You know, really nice quarter with the 27% growth, and you're expecting at least 20% for the full year, which implies a decel as we make our way through the year.”
“I guess just to start, again, on the SBA regulatory process and the submissions, could you just help us think about how you're thinking of the timelines over the next few months and what are kind of the guideposts we should be looking out for?”
Jeffries
Analyst
Transcript header (unverified)
Medical Instruments & Supplies · Healthcare
AXGN
Medical Devices · Healthcare
CTSO
Medical Devices · Healthcare
